Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP & Chief Commercial Officer
-
Issuer Symbol
-
RARE on Nasdaq
Erik Harris - trading volume in the past year for Ultragenyx Pharmaceutical Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
87,855 |
$3,698,696 |
$42.10 |
03 Mar 2025 |
Direct |
|
|
| Stock Option (Right to Buy) |
30,246 |
|
|
01 Mar 2025 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.